The pooled HR of overall survival indicated that no statistically significance was founded between mTOR/p-mTOR expression and NSCLC patients’ prognosis, using both univariate analysis and multivariate analysis, with significant heterogeneity. This evidence concerns the gene MTOR and non-small cell lung carcinoma.